References
- Roach PJ. Glycogen and its metabolism. Curr Mol Med 2002;2:101–120.
- Saltik IN, Ozen H, Ciliv G, et al. Glycogen storage disease type 1a: frequency and clinical course in Turkish children. Indian J Pediatr 2000;67:497–501.
- Annabi B, Hiraiwa H, Mansfield BC, et al. The gene for glycogen-storage disease type 1b maps to chromosome 11q23. Am J Hum Genet 1998;62:400–405.
- Ihara K, Kuromaru R, Hara T. Genomic structure of the human glucose 6-phosphate translocase gene and novel mutations in the gene of a Japanese patient with glycogen storage disease type 1b. Hum Genet 1998;103:493–496.
- Özen H. Glycogen storage diseases: new perspectives. World J Gastroenterol 2007;13:2541–2553.
- Visser G, Rake JP, Fernandes J, et al. Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type 1b: results of the European Study on Glycogen Storage Disease type I. J Pediatr 2000;137:187–191.
- Wilson WA. Ocular findings in several metabolic diseases. Calif Med 1969 Dec;111:446–449.
- Ayala-Ramirez R, Graue-Wiechers F, Robredo V, et al. A new autosomal recessive syndrome consisting of posterior microphthalmos, retinitis pigmentosa, foveoschisis, and optic disc drusen is caused by a MFRP gene mutation. Mol Vis 2006;12:1483–1489.
- Crespí J, Buil JA, Bassaganyas F, et al. A novel mutation confirms MFRP as the gene causing the syndrome of nanophthalmos-retinitis pigmentosa-foveoschisis-optic disk drusen. Am J Ophthalmol 2008;146:323–328.
- Sundin OH, Leppert GS, Silva ED, et al. Extreme hyperopia is the result of null mutations in MFRP, which encodes a frizzled-related protein. Proc Nat Lacad Sci USA 2005;102:9553–9558.
- Zenteno JC, Buentello-Volante B, Quiroz-Gonzalez MA, et al. Compound heterozygosity for a novel and a recurrent MFRP gene mutation in a family with the nanophthalmos-retinitis pigmentosa complex. Mol Vis 2009;15:1794–1798.
- Matsushita I1, Kondo H, Tawara A. Novel compound heterozygous mutations in the MFRP gene in a Japanese patient with posterior microphthalmos. Jpn J Ophthalmol 2012;56:396–400.
- Mandal MN, Vasireddy V, Jablonski MM, et al. Spatial and temporal expression of MFRP and its interaction with CTRP5. Invest Ophthalmol Vis Sci 2006;47:5514–5521.
- Dl1 M, Mf M, Mg B, et al. ISCEV Standard for full-field clinical electroretinography. Doc Ophthalmol 2015;130:1–12.
- Adzhubei I, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248–249.
- Pc1 N, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res 2001;11:863–874.
- Katoh M. Molecular cloning and characterization of MFRP, a novel gene encoding a membrane-type Frizzled-related protein. Biochembiophys Res Commun 2001;282:116–123.
- Sundin OH, Dharmaraj S, Buhotto IA, et al. Developmental basis of nanophthalmos: MFRP is required for both prenatal ocular growth and postnatal emmetropization. Ophthalmic Genet 2008;29:1–9.
- Spitznas M, Gerke E, Bateman JB. Hereditary posterior microphthalmos with papillomacular fold and high hyperopia. Arch Ophthalmol 1983;101:413–417.
- Goldblum D, Mojon DS. Posterior microphthalmos associated with papillomacular fold and high hyperopia. J Pediatrophthalmol Strabismus 1999;36:351–352.
- Huang S, Yu M, Qiu C, et al. The management of secondary glaucoma in nanophthalmic patients. Yan Kexuebao 2002;18:156–159.
- Mukhopadhyay R, Sergouniotis PI, Mackay DS, et al. A detailed phenotypic assessment of individuals affected by MFRP-related oculopathy. Mol Vis 2010;16:540–548.